A randomized open label clinical trial of an anti HPV biological dressing (JB01 BD) administered intravaginally to treat high risk HPV infection.
Currently, there is no specific antiviral therapy for HPV infection. We conducted a randomized open label clinical trial of JB01 BD, an anti HPV biological dressing from Shanxi Jinbo Pharmaceutical Co. Ltd. China, for treatment of HPV infection. Seventy seven women with cervical infection by high risk HPV were randomly divided into a treatment group and a non treatment group. After treatment, about 60.5% (23/38) of HPV positive women in the treatment group became HPV negative compared with 13.5% (5/37) of women in the non treatment group becoming HPV negative (P 0.001) These data suggest that JB01 BD is an effective topical biological agent for the treatment of cervical HPV infection.
Microbes and infection